Brain Res, 2015 · DOI: 10.1016/j.brainres.2015.10.022 · Published: December 10, 2015
Glial restricted precursors (GRPs) are a type of cell that shows promise for treating spinal cord injuries because they can create an environment that supports nerve fiber growth. This study investigated whether GRPs maintain their beneficial properties after being grown in large numbers in the lab, a process necessary for transplantation therapies. The researchers found that GRPs grown for extended periods still had the ability to promote nerve fiber growth, similar to GRPs grown for shorter periods. However, when GRPs were exposed to inflammatory substances, their growth-promoting effects were reduced. This suggests that while GRPs can be expanded for transplantation without losing their key properties, it's important to control inflammation in the injured spinal cord to ensure the GRPs can effectively support nerve regeneration.
GRP can be expanded in vitro for transplantation therapy in SCI repair due to their maintained permissive characteristics.
Modulating the inflammatory environment of the injured CNS is crucial to enhance the efficacy of GRP transplants.
The in vitro co-culture system is valuable for testing and screening cell properties before applying them to transplantation protocols.